Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)

Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)

  • December 2020 •
  • 98 pages •
  • Report ID: 5996842 •
  • Format: PDF
Scope of the Report
The report entitled “Global Biologics Market: Size & Forecasts with Impact Analysis of Covid-19 (2020-2024 Edition)”, provides an in-depth analysis of the global biologics market with detailed analysis of the market in terms of value and segments.

The report includes a brief regional analysis of North America, South America, Europe, Asia Pacific and Middle East & Africa with their actual and forecasted market size. Under competitive landscape, key competitors in the market have been compared on the basis of share.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2020-2024 , taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.

Company Coverage
Abbvie Inc
Samsung Electronics (Samsung Biologics)
F.Hoffmann La Roche
Amgen Inc.

Regional Coverage
North America
South America
Asia Pacific
Middle East and Africa

Executive Summary
The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2020-2024. The market is supported by various growth drivers such as rise in sedentary lifestyle, hike in spending on healthcare, increasing biologics approval, growing incidence of chronic conditions among the aging population, increased availability of advanced diagnostics, rising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases and advancement in healthcare & biotechnology.

Yet the market faces some restraints which are obstructing the growth of the market. Some of the major challenges faced by the industry are emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges. Ongoing Covid-19 pandemic is posing challenges for the market as far as the year 2020 is concerned.

We are very sorry, but an error occurred.
Please contact if the problem remains.